Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00828269 | Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123) | PHASE1 | COMPLETED | 12 | — | — | Apr 1, 2009 | Mar 1, 2010 | Apr 22, 2015 | - | — |
| Arm | Type | Description |
|---|---|---|
| 1 | NO_INTERVENTION | Liver tissue biopsy |
| Name | Type | Description |
|---|---|---|
| Comparator: Fine needle aspiration biopsy | PROCEDURE | Visit 1: Screening Visit 2 (7-14 days from screening): Core needle biopsy and fine needle aspiration biopsy - liver. Visit 3:(7 days from visit 2): Fine needle aspiration biopsy - liver. Visit 4: (14 days from Visit 3): follow-up visit |
Inclusion Criteria: * Patient has chronic hepatitis C (Genotype 1) * Patient has the ability to avoid use of anticoagulants, nonsteroidal anti-inflammatory drugs and aspirin for at least 5 days before the liver biopsy Exclusion Criteria: * Patient has received any approved or investigational drug...